Zobrazeno 1 - 10
of 296
pro vyhledávání: '"Darren R. Brenner"'
Autor:
Anna Pujadas Botey, Tara R. Bond, Eliya Farah, Chantelle Carbonell, Stacey Dyck, Angela Estey, Douglas A. Stewart, Darren R. Brenner, Paula J. Robson
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1470-1476 (2024)
This commentary provides a detailed overview of the extensive stakeholder engagement efforts critical to the development of the Future of Cancer Impact (FOCI) in Alberta report. The overarching aim of the FOCI report was to support informed and strat
Externí odkaz:
https://doaj.org/article/e91e60966a664a25b8b858bfdad194da
Autor:
Amman Yusuf, Devon J. Boyne, Dylan E. O’Sullivan, Darren R. Brenner, Winson Y. Cheung, Imran Mirza, Tamer N. Jarada
Publikováno v:
BMC Medical Research Methodology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Laboratory data can provide great value to support research aimed at reducing the incidence, prolonging survival and enhancing outcomes of cancer. Data is characterized by the information it carries and the format it holds. Data c
Externí odkaz:
https://doaj.org/article/77ba153438d140d9b7e9a161a79c415b
Autor:
Matthew T. Warkentin, Yibing Ruan, Larry F. Ellison, Jean-Michel Billette, Alain Demers, Fei-Fei Liu, Darren R. Brenner
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In Canada, the absolute number of cancer deaths has been steadily increasing, however, age-standardized cancer mortality rates peaked decades ago for most cancers. The objective of this study was to estimate the reduction in deaths for each
Externí odkaz:
https://doaj.org/article/f8f151473c9947d195118dad9d955157
Publikováno v:
Cancer Medicine, Vol 13, Iss 13, Pp n/a-n/a (2024)
Abstract Objectives Randomized controlled trials (RCTs) are the gold standard for evaluating the comparative efficacy and safety of new cancer therapies. However, enrolling patients in control arms of clinical trials can be challenging for rare cance
Externí odkaz:
https://doaj.org/article/919b0151574f4e5088d744bcff3ac847
Autor:
Dylan E. O’Sullivan, Devon J. Boyne, Chelsea Ford-Sahibzada, Jessica A. Inskip, Christopher J. Smith, Kaushik Sripada, Darren R. Brenner, Winson Y. Cheung
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 447-461 (2024)
The prognosis of early non-small-cell lung cancer (eNSCLC) remains poor. An understanding of current therapies and outcomes can provide insights into how novel therapies can be integrated into clinics. We conducted a large, retrospective, population-
Externí odkaz:
https://doaj.org/article/f9486525b3da431ea9bbe60f8f56da70
Autor:
Zhao Wu Meng, Yibing Ruan, Stacey Fisher, Kirles Bishay, Millie Chau, Megan Howarth, Shane Cartwright, Yen‐I Chen, Elijah Dixon, Steven J. Heitman, Darren R. Brenner, Nauzer Forbes
Publikováno v:
DEN Open, Vol 4, Iss 1, Pp n/a-n/a (2024)
Abstract Background Pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP) can lead to significant morbidity and mortality. We aimed to develop an accurate post‐ERCP pancreatitis risk prediction model using easily obtainable v
Externí odkaz:
https://doaj.org/article/a674abea724e4b658f62f18c6f64d03e
Autor:
Chantelle Carbonell BHSc, Mariet Mathew Stephen MSc, Yibing Ruan PhD, Matthew T. Warkentin PhD, Darren R. Brenner PhD
Publikováno v:
Cancer Control, Vol 31 (2024)
Background: Western populations are losing the battle over healthy weight management, and excess body weight is a notable cancer risk factor at the population level. There is ongoing interest in pharmacological interventions aimed at promoting weight
Externí odkaz:
https://doaj.org/article/4755900f206b409cb8897ebd38f7b5da
Autor:
Darren R. Brenner, Chantelle Carbonell, Dylan E. O’Sullivan, Yibing Ruan, Robert B. Basmadjian, Vickey Bu, Eliya Farah, Shaun K. Loewen, Tara R. Bond, Angela Estey, Anna Pujadas Botey, Paula J. Robson
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9981-9995 (2023)
The impact of cancer in Alberta is expected to grow considerably, largely driven by population growth and aging. The Future of Cancer Impact (FOCI) initiative offers an overview of the present state of cancer care in Alberta and highlights potential
Externí odkaz:
https://doaj.org/article/32084b29258041b68703925892df16ca
Autor:
Safiya Karim, Jennifer Lowther, Gabriel Gyulay, Dylan O’Sullivan, Christopher J. D. Wallis, Steven M. Yip, Darren R. Brenner, Devon J. Boyne, Winson Y. Cheung
Publikováno v:
Current Oncology, Vol 30, Iss 9, Pp 8149-8158 (2023)
Introduction: Over the past decade, the treatment of metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly. Current guidelines suggest the use of androgen deprivation therapy (ADT) plus an additional systemic therapy, rega
Externí odkaz:
https://doaj.org/article/3d13741c0c444fc0ada6fdd1c670e619
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 4166-4176 (2023)
Immunotherapy and targeted therapies have been shown to considerably improve long-term survival outcomes in metastatic melanoma patients. Real-world evidence on the uptake of novel therapies and outcomes for this patient population in Canada are limi
Externí odkaz:
https://doaj.org/article/3f665b4e91c542b98233d44765fec296